PUBLISHER: The Business Research Company | PRODUCT CODE: 1997987
PUBLISHER: The Business Research Company | PRODUCT CODE: 1997987
Nicotine gum is a form of chewing gum designed to include a small amount of nicotine, which is absorbed into the bloodstream through the mouth lining. This method aims to reduce nicotine cravings and alleviate symptoms associated with quitting smoking, thereby helping individuals manage the urge to smoke. Notably, nicotine gum is available without the need for a prescription.
The primary variations of nicotine gum include 2 mg, 4 mg, and 6 mg nicotine gums. The 2 mg nicotine gum is classified as a nicotine replacement therapy (NRT) product, containing 2 milligrams (mg) of nicotine per piece. It serves as a smoking cessation aid, effectively mitigating cravings and withdrawal symptoms linked to the cessation of smoking or chewing tobacco. These nicotine gums are offered in both flavored and plain varieties, and they are distributed through various channels. Retail pharmacies, specialty stores, online platforms, and other distribution channels cater to a diverse range of consumers, including those seeking support at withdrawal clinics, medical practices, individual smokers, and more. The accessibility of nicotine gum through these channels contributes to its widespread use as a smoking cessation aid.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Tariffs are influencing the nicotine gum market by increasing costs of imported pharmaceutical-grade nicotine, excipients, flavoring agents, and packaging materials. North America and Europe are most affected due to reliance on imported active ingredients, while Asia-Pacific faces cost pressures in export-oriented manufacturing. These tariffs are impacting production costs and retail pricing. However, they are also encouraging local sourcing of inputs, regional manufacturing expansion, and supply chain diversification for nicotine replacement therapies.
The nicotine gum market research report is one of a series of new reports from The Business Research Company that provides nicotine gum market statistics, including nicotine gum industry global market size, regional shares, competitors with a nicotine gum market share, detailed nicotine gum market segments, market trends and opportunities, and any further data you may need to thrive in the nicotine gum industry. This nicotine gum market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nicotine gum market size has grown strongly in recent years. It will grow from $1.84 billion in 2025 to $1.95 billion in 2026 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to expansion of public health anti-smoking campaigns, increasing awareness of smoking-related health risks, availability of non-prescription cessation aids, growth of retail pharmacy networks, acceptance of nicotine replacement therapy.
The nicotine gum market size is expected to see strong growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing focus on preventive healthcare, rising demand for convenient cessation solutions, expansion of digital health support programs, growing regulatory support for harm reduction products, increasing innovation in nicotine delivery formats. Major trends in the forecast period include increasing demand for smoking cessation products, rising adoption of over-the-counter nicotine therapies, growing preference for flavored nicotine gum variants, expansion of online distribution channels, enhanced focus on controlled nicotine delivery.
The rising tobacco prices are expected to drive the growth of the nicotine gum market going forward. Tobacco, a plant from the Nicotiana genus in the Solanaceae family, has seen increasing costs, making nicotine gum a comparatively affordable and effective alternative for individuals seeking to quit smoking. For instance, in October 2024, according to the Office for National Statistics, a UK-based non-ministerial department, the average price of a King 20-pack of cigarettes rose from 1261 pence ($16.48) in 2022 to 1425 pence ($18.63) in 2023. Therefore, increasing tobacco prices are fueling the nicotine gum market.
Major companies in the nicotine gum market are introducing innovative products such as lozenges to maintain a competitive edge. Lozenges are small, medicated tablets or candies that dissolve slowly in the mouth to provide relief or deliver active ingredients. For example, in May 2023, Perrigo Company PLC, an Ireland-based provider of over-the-counter self-care products, launched FDA-approved Nicotine Coated Mint Lozenges. Available in 2 mg and 4 mg strengths without a prescription, these lozenges help ease nicotine withdrawal symptoms, supporting individuals in quitting smoking. The mint-coated formulation enhances taste and user experience, providing a convenient and accessible option for reducing dependence on cigarettes. This launch strengthens Perrigo's position in the smoking cessation market.
In September 2024, Dr. Reddy's Laboratories, an India-based pharmaceutical company, acquired Haleon plc for $597.57 million. The main goal of this acquisition is to strengthen Dr. Reddy's presence in the consumer healthcare sector, specifically in the nicotine replacement therapy (NRT) category. Haleon plc is a UK-based consumer healthcare company that produces nicotine gum.
Major companies operating in the nicotine gum market are Pfizer Inc., GlaxoSmithKline plc, Haleon plc, Perrigo Company plc, Johnson & Johnson, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Novartis AG, Fertin Pharma A/S, British American Tobacco plc, ITC Limited, Niconovum AB, Enorama Pharma AB, NicoBloc Ltd., BGP Healthcare, Apotex Inc., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Sun Pharmaceutical Industries Ltd., Johnson Matthey Health
North America was the largest region in the nicotine gum market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotine gum market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nicotine gum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada
The nicotine gum market consists of sales of regular strengthen gums, extra-strength gums, and nicotine polacrilex gum. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nicotine Gum Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses nicotine gum market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for nicotine gum ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nicotine gum market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.